CN102078578A - Traditional Chinese medicine composition for treating enuresis due to spleen-lung vital energy deficiency - Google Patents
Traditional Chinese medicine composition for treating enuresis due to spleen-lung vital energy deficiency Download PDFInfo
- Publication number
- CN102078578A CN102078578A CN2009102520071A CN200910252007A CN102078578A CN 102078578 A CN102078578 A CN 102078578A CN 2009102520071 A CN2009102520071 A CN 2009102520071A CN 200910252007 A CN200910252007 A CN 200910252007A CN 102078578 A CN102078578 A CN 102078578A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- radix
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses traditional Chinese medicine composition for treating the enuresis due to spleen-lung vital energy deficiency, which is prepared from the following active pharmaceutical ingredients in parts by weight: 10-40 parts of ginseng, 10-60 parts of radix astragali, 10-30 parts of white atractylodes rhizome, 10-30 parts of yam, 10-30 parts of tuckahoe, 10-30 parts of bugbane, 10-20 parts of radix bupleuri, 10-20 parts of dried ginger, 10-20 parts of fructus zingiberis nigri, 10-20 parts of angelica, 10-20 parts of baked ginger and 5-10 parts of liquorice. The traditional Chinese medicine composition disclosed by the invention is prepared by adopting the modern latest achievements in scientific research on the basis of the traditional Chinese medicine differentiation therapy, is prepared from various medicines and has the characteristics of definite curative effect, safety, convenience, no toxic or side effect and low cost.
Description
Technical field
The invention belongs to tcm field, relate in particular to a kind of Chinese medicine composition for the treatment of enuresis disease.
Background technology
The enuresis is meant children's more than three years old in bed, and involuntary urinating is commonly called as bed-wetting.If infant period, because passages through which vital energy circulates is not contained on the physiology, QI and blood is not filled, and internal organs are hard, and intelligence is incomplete, and is relatively poor to the self-control of urinating; School age population is also often excessive because of the daytime recreation, mental fatigue, and the reasons such as preceding polydipsia of sleeping, the accidental enuresis that takes place, these do not belong to morbid state.But surpass 3 years old, particularly the child more than 5 years old can not Autonomous Control urinate, and the frequent enuresis when sleeping soundly then is a morbid state.Bed-wetting comprises two kinds of the enuresis of primary enuresis and organic disease, does not wherein have the morbidity degree of the primary enuresis of obvious urinary tract or nervous system organic disease to account for the 70-80% of bed-wetting.Modern medicine thinks that urinating is a complex physical process, is a kind of reflexive activity that is subjected to brain micturition centre control.Because the cerebral cortex dysfunction that a variety of causes causes will cause the generation of enuresis disease.Bed-wetting main with inherited genetic factors, slept deeply, factors such as bladder function delay of maturation, psychentonia or organic disease are relevant, but the definite reason of the enuresis still imperfectly understands at present.At present, the Chinese medicine therapy is adopted in the treatment of infantile enuresis more.Mainly contain methods such as Chinese medicine, acupuncture, massage, tcm herbal ion importing, the treatment of bed-wetting is all had curative effect preferably, China's tradition Chinese medicine is with the obvious advantage to the treatment of bed-wetting, and the enuresis of determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs treatment clinically can obtain good effect.Invent a kind of not only safety but also effective Chinese medicine preparation, be significant.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine composition for the treatment of the deficiency of both the splenic and pulmonary QI enuresis.
The Chinese medicine composition of the treatment deficiency of both the splenic and pulmonary QI enuresis of the present invention is made by following materials of weight proportions medicine:
Radix Ginseng 10-40 part, Radix Astragali 10-60 part, Rhizoma Atractylodis Macrocephalae 10-30 part, Rhizoma Dioscoreae 10-30 part, Poria 10-30 part, Rhizoma Cimicifugae 10-30 part, Radix Bupleuri 10-20 part, Rhizoma Zingiberis 10-20 part, Fructus Alpiniae Oxyphyllae 10-20 part, Radix Angelicae Sinensis 10-20 part, Rhizoma Zingiberis Preparatum 10-20 part, Radix Glycyrrhizae 5-10 part.
The optimum ratio of the Chinese medicine composition of the treatment deficiency of both the splenic and pulmonary QI enuresis of the present invention is:
Radix Ginseng 15-35 part, Radix Astragali 20-40 part, Rhizoma Atractylodis Macrocephalae 15-25 part, Rhizoma Dioscoreae 15-25 part, Poria 15-25 part, Rhizoma Cimicifugae 15-25 part, Radix Bupleuri 12-18 part, Rhizoma Zingiberis 12-18 part, Fructus Alpiniae Oxyphyllae 12-18 part, Radix Angelicae Sinensis 12-18 part, Rhizoma Zingiberis Preparatum 12-18 part, Radix Glycyrrhizae 6-8 part.
The best proportioning of the Chinese medicine composition of the treatment deficiency of both the splenic and pulmonary QI enuresis of the present invention is:
24 parts of Radix Ginsengs, 30 parts of the Radixs Astragali, 20 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts of Rhizoma Dioscoreaes, 20 parts in Poria, 20 parts of Rhizoma Cimicifugaes, 15 parts of Radix Bupleuri, 15 parts of Rhizoma Zingiberiss, 15 parts of Fructus Alpiniae Oxyphyllae, 15 parts of Radix Angelicae Sinensis, 15 parts of Rhizoma Zingiberis Preparatums, 7 parts in Radix Glycyrrhizae.
Chinese medicine composition of the present invention is to develop in conjunction with the latest modern technological scientific achievement on the basis of traditional tcm syndrome differentiation and treatment.Have determined curative effect, safe ready, have no side effect, cheap characteristics.
The specific embodiment
Embodiment 1
The Chinese medicine composition of present embodiment is formed by following materials of weight proportions medication preparation:
40 parts of Radix Ginsengs, 60 parts of the Radixs Astragali, 30 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Rhizoma Dioscoreaes, 30 parts in Poria, 30 parts of Rhizoma Cimicifugaes, 20 parts of Radix Bupleuri, 20 parts of Rhizoma Zingiberiss, 20 parts of Fructus Alpiniae Oxyphyllae, 20 parts of Radix Angelicae Sinensis, 20 parts of Rhizoma Zingiberis Preparatums, 10 parts in Radix Glycyrrhizae.
The preparation method of present embodiment Chinese medicine composition is as follows:
Raw medicinal material is ground into coarse powder, decocts 3 times each 3 hours with 8 times of water gagings, decocting liquid filters, merging filtrate, and being concentrated into relative density under 50～90 ℃ of temperature is the clear paste of 1.1.10～1.35 (under 60 ℃), add sucrose, dextrin, mixing is made granule, dry, granulate, molding, packing, check gets product.
Embodiment 2
The Chinese medicine composition of present embodiment is formed by following materials of weight proportions medication preparation, and preparation method is with embodiment 1.
10 parts of Radix Ginsengs, 10 parts of the Radixs Astragali, 10 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of Rhizoma Dioscoreaes, 10 parts in Poria, 10 parts of Rhizoma Cimicifugaes, 10 parts of Radix Bupleuri, 10 parts of Rhizoma Zingiberiss, 10 parts of Fructus Alpiniae Oxyphyllae, 10 parts of Radix Angelicae Sinensis, 10 parts of Rhizoma Zingiberis Preparatums, 5 parts in Radix Glycyrrhizae.
Embodiment 3
The Chinese medicine composition of present embodiment is formed by following materials of weight proportions medication preparation, and preparation method is with embodiment 1.
15 parts of Radix Ginsengs, 20 parts of the Radixs Astragali, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Rhizoma Dioscoreaes, 15 parts in Poria, 15 parts of Rhizoma Cimicifugaes, 12 parts of Radix Bupleuri, 12 parts of Rhizoma Zingiberiss, 12 parts of Fructus Alpiniae Oxyphyllae, 12 parts of Radix Angelicae Sinensis, 12 parts of Rhizoma Zingiberis Preparatums, 6 parts in Radix Glycyrrhizae.
Embodiment 4
The Chinese medicine composition of present embodiment is formed by following materials of weight proportions medication preparation, and preparation method is with embodiment 1.
35 parts of Radix Ginsengs, 40 parts of the Radixs Astragali, 25 parts of the Rhizoma Atractylodis Macrocephalaes, 25 parts of Rhizoma Dioscoreaes, 25 parts in Poria, 25 parts of Rhizoma Cimicifugaes, 18 parts of Radix Bupleuri, 18 parts of Rhizoma Zingiberiss, 18 parts of Fructus Alpiniae Oxyphyllae, 18 parts of Radix Angelicae Sinensis, 18 parts of Rhizoma Zingiberis Preparatums, 8 parts in Radix Glycyrrhizae.
Embodiment 5
The Chinese medicine composition of present embodiment is formed by following materials of weight proportions medication preparation, and preparation method is with embodiment 1.
24 parts of Radix Ginsengs, 30 parts of the Radixs Astragali, 20 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts of Rhizoma Dioscoreaes, 20 parts in Poria, 20 parts of Rhizoma Cimicifugaes, 15 parts of Radix Bupleuri, 15 parts of Rhizoma Zingiberiss, 15 parts of Fructus Alpiniae Oxyphyllae, 15 parts of Radix Angelicae Sinensis, 15 parts of Rhizoma Zingiberis Preparatums, 7 parts in Radix Glycyrrhizae.
Claims (3)
1. Chinese medicine composition for the treatment of the deficiency of both the splenic and pulmonary QI enuresis is characterized in that it is made by following materials of weight proportions medicine:
Radix Ginseng 10-40 part, Radix Astragali 10-60 part, Rhizoma Atractylodis Macrocephalae 10-30 part, Rhizoma Dioscoreae 10-30 part, Poria 10-30 part, Rhizoma Cimicifugae 10-30 part, Radix Bupleuri 10-20 part, Rhizoma Zingiberis 10-20 part, Fructus Alpiniae Oxyphyllae 10-20 part, Radix Angelicae Sinensis 10-20 part, Rhizoma Zingiberis Preparatum 10-20 part, Radix Glycyrrhizae 5-10 part.
2. the Chinese medicine composition of the treatment deficiency of both the splenic and pulmonary QI enuresis according to claim 1 is characterized in that the weight proportion of described crude drug is:
Radix Ginseng 15-35 part, Radix Astragali 20-40 part, Rhizoma Atractylodis Macrocephalae 15-25 part, Rhizoma Dioscoreae 15-25 part, Poria 15-25 part, Rhizoma Cimicifugae 15-25 part, Radix Bupleuri 12-18 part, Rhizoma Zingiberis 12-18 part, Fructus Alpiniae Oxyphyllae 12-18 part, Radix Angelicae Sinensis 12-18 part, Rhizoma Zingiberis Preparatum 12-18 part, Radix Glycyrrhizae 6-8 part.
3. the Chinese medicine composition of the treatment deficiency of both the splenic and pulmonary QI enuresis according to claim 1 is characterized in that the weight proportion of described crude drug is:
24 parts of Radix Ginsengs, 30 parts of the Radixs Astragali, 20 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts of Rhizoma Dioscoreaes, 20 parts in Poria, 20 parts of Rhizoma Cimicifugaes, 15 parts of Radix Bupleuri, 15 parts of Rhizoma Zingiberiss, 15 parts of Fructus Alpiniae Oxyphyllae, 15 parts of Radix Angelicae Sinensis, 15 parts of Rhizoma Zingiberis Preparatums, 7 parts in Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102520071A CN102078578A (en) | 2009-12-01 | 2009-12-01 | Traditional Chinese medicine composition for treating enuresis due to spleen-lung vital energy deficiency |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102520071A CN102078578A (en) | 2009-12-01 | 2009-12-01 | Traditional Chinese medicine composition for treating enuresis due to spleen-lung vital energy deficiency |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102078578A true CN102078578A (en) | 2011-06-01 |
Family
ID=44084905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102520071A Pending CN102078578A (en) | 2009-12-01 | 2009-12-01 | Traditional Chinese medicine composition for treating enuresis due to spleen-lung vital energy deficiency |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102078578A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103462023A (en) * | 2013-09-24 | 2013-12-25 | 马松江 | Herbal diet therapy composition with function of tonifying spleen and lung and preparation method thereof |
| CN103768556A (en) * | 2013-10-30 | 2014-05-07 | 浙江省中医院 | Traditional Chinese medicine composition and traditional Chinese medicine conditioning unguent for recuperative medical care for habitus with deficiency of vital energy |
| CN104381543A (en) * | 2014-12-02 | 2015-03-04 | 鲍显诵 | Tea with functions of raising yang and consolidating foundation |
| CN104922542A (en) * | 2015-07-20 | 2015-09-23 | 冉宇欣 | Medicine for treating spleen-lung qi deficiency infantile enuresis and preparation method thereof |
| CN105412780A (en) * | 2015-11-26 | 2016-03-23 | 苏吉永 | Traditional Chinese medicine for treating spleen-lung qi deficiency type child enuresis |
-
2009
- 2009-12-01 CN CN2009102520071A patent/CN102078578A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103462023A (en) * | 2013-09-24 | 2013-12-25 | 马松江 | Herbal diet therapy composition with function of tonifying spleen and lung and preparation method thereof |
| CN103462023B (en) * | 2013-09-24 | 2016-05-11 | 马松江 | A kind of have strengthening the spleen and tonifying the lung draft food therapeutic composition of function and preparation method thereof |
| CN103768556A (en) * | 2013-10-30 | 2014-05-07 | 浙江省中医院 | Traditional Chinese medicine composition and traditional Chinese medicine conditioning unguent for recuperative medical care for habitus with deficiency of vital energy |
| CN103768556B (en) * | 2013-10-30 | 2016-04-27 | 浙江省中医院 | A kind of Chinese medicine composition and Chinese medicine conditioning cream recuperating under medical treatment Qi deficiency physique |
| CN104381543A (en) * | 2014-12-02 | 2015-03-04 | 鲍显诵 | Tea with functions of raising yang and consolidating foundation |
| CN104922542A (en) * | 2015-07-20 | 2015-09-23 | 冉宇欣 | Medicine for treating spleen-lung qi deficiency infantile enuresis and preparation method thereof |
| CN105412780A (en) * | 2015-11-26 | 2016-03-23 | 苏吉永 | Traditional Chinese medicine for treating spleen-lung qi deficiency type child enuresis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102078470A (en) | Traditional Chinese medicine composition for treating vital energy stagnation blood stasis type dysmenorrhea | |
| CN103948786B (en) | Traditional Chinese medicine for treating diabetes | |
| CN101112606A (en) | Traditional Chinese medicine for treating enteritis | |
| CN103800788A (en) | Traditional Chinese medicine preparation for treating infantile enuresis | |
| CN102397372A (en) | Medicinal composition and pharmaceutical preparation and application thereof to treating irritable bowel syndrome | |
| CN102078578A (en) | Traditional Chinese medicine composition for treating enuresis due to spleen-lung vital energy deficiency | |
| CN101433652A (en) | Medicament for treating paediatrics laxness | |
| CN104352998A (en) | Traditional Chinese medicine composition for treating severe insomnia | |
| CN102327377B (en) | Traditional Chinese medicine composition for treating functional dyspepsia | |
| CN104147486A (en) | Traditional Chinese medicine for treating pediatric enuresis | |
| CN101513481A (en) | Pure Chinese medicinal preparation for treating infantile enuresis, and preparation method thereof | |
| CN103127351B (en) | Traditional Chinese medicine for treating premature menstruation | |
| CN102631450B (en) | Traditional Chinese medicine (TCM) decoction for treating wind-cold type common cold | |
| CN102284053B (en) | Foot bathing preparation for treating insomnia | |
| CN102697957B (en) | Traditional Chinese medicine prescription for treating dampness-heat in spleen stomach | |
| CN102178768B (en) | Chinese medicine composition for treating horse damp and hot diarrhea and preparation method thereof | |
| CN104147526A (en) | Traditional Chinese medicine particles for treating icteric hepatitis and preparation method thereof | |
| CN104127657A (en) | Traditional Chinese medicine for treating blood-stasis type functional uterine bleeding and preparation method thereof | |
| CN102078553A (en) | Chinese medicine composition for treating liver meridian damp heat enuresis | |
| CN103142914B (en) | Traditional Chinese medicine for lowering blood sugar | |
| CN103099879B (en) | Traditional Chinese medicine (TCM) preparation for treating fifth-watch diarrhea | |
| CN102078552A (en) | Traditional Chinese medicine composition for treating enuresis due to kidney-qi asthenia cold | |
| CN104667050A (en) | Traditional Chinese medicine for treating insomnia | |
| CN105311556A (en) | Traditional Chinese medicine granules for treating jaundice hepatitis and preparation method thereof | |
| CN104587175A (en) | Formula of traditional Chinese medicine for treating diabetes mellitus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DD01 | Delivery of document by public notice |
Addressee: Fu Zhicheng Document name: Notification of Passing Preliminary Examination of the Application for Invention |
|
| C06 | Publication | ||
| PB01 | Publication | ||
| DD01 | Delivery of document by public notice |
Addressee: Fu Zhicheng Document name: Notification of before Expiration of Request of Examination as to Substance |
|
| DD01 | Delivery of document by public notice |
Addressee: Fu Zhicheng Document name: Notification that Application Deemed to be Withdrawn |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110601 |